Abstract
Introduction Standardization in healthcare is crucial for comprehensive patient care, as emphasized by the WHO and quality management principles. Clinical pathways offer a structured approach to describing essential processes, particularly relevant in gynecologic oncology care. Despite their proven benefits, pathways remain underutilized, highlighting the need for explicit translation of implicit pathways.
Materials and Methods This study employed semi-structured interviews with healthcare professionals to capture implicit gynecologic oncology pathway. Interviews were examined using qualitative content analysis. External requirements, legal mandates, and certification criteria were integrated into pathway development. A participatory approach involving interprofessional collaboration guided pathway refinement.
Results The study applied the Pathway Association’s 7-phase method, illustrating the development of VivaPathway GT. The explicit pathway, enriched with external requirements, comprised 26 steps, enhancing comprehensiveness and interprofessional involvement. Notable additions included pre-therapeutic tumor boards and detailed post-operative consultations.
Discussion Transitioning from implicit to explicit pathways is a is a demanding and challenging process emphasizing stakeholder engagement and IT support. Financial constraints pose challenges, but initiatives like quality contracts offer opportunities for resource allocation. The study validates hypotheses, confirming the efficacy of collaboration of involved professionals and integration of external requirements in pathway development.
Conclusions This study underscores the importance of explicit clinical pathways. It provides valuable insights for healthcare professionals facing similar challenges, emphasizing the need for ongoing evaluation and adaptation. Despite resource challenges, stakeholder collaboration and IT support are crucial for pathway effectiveness and relevance in evolving healthcare landscapes.
Competing Interest Statement
Competing Interests Statement: The authors of this manuscript declare the following potential competing interests in accordance with PLOS guidelines: Anne Büscher: As the administrative manager at Vivantes Klinikum Friedrichshain, I am administratively involved in the implementation and management of the clinical pathway discussed in this manuscript. My role involves general administrative and managerial functions within the whole hospital. Dr. Nicolle Reinhold: Dr. Reinhold is a senior physician in gynecology at Vivantes Klinikum Friedrichshain and directly involved in patient care and the development of gynecologic oncology practices. All interviews conducted for this research involved participants associated with Vivantes Klinikum Friedrichshain, and their identities are familiar to the authors due to their roles within the hospital. No financial interests, employment, consultancy, or any other competing interests that could compromise the objectivity of this research are present. This statement is made to ensure transparency and adhere to PLOS policy on competing interests.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
Data Availability
No, the data are available from the author and are not publicly accessible. The reason for this is due to the methodology of the study: in the interviews, we always chose only one profession per interview participant (except for the gynecologists). Making the data publicly available would not maintain the promised anonymity of the participants, which would be in conflict with the ethical guidelines of our research. For this reason, we have decided to make the data available only upon direct request, in order to protect the privacy and anonymity of the interview participants. Data are available from the first author for researchers who meet the criteria for access to confidential data.
